Stay updated on Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.

Latest updates to the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedAdded related topic MedlinePlus Genetics and updated location references (Florida); the page revision was updated to v3.3.3 and HHS Vulnerability Disclosure and Florida Locations were removed.SummaryDifference0.4%

- Check53 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page, an internal versioning change that does not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the generic government funding/operating status notice from the page; it does not affect study details or access. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedMelanoma and related MedlinePlus Genetics topics were removed from the page.SummaryDifference0.7%

- Check96 days agoChange DetectedAdded new MedlinePlus Genetics topic: Melanoma. No deletions.SummaryDifference0.2%

Stay in the know with updates to Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.